Hester Biosciences Ltd.
•₹ 2,367.8-1.88%
2026-08-21
PROS
- Latest quarter profit grew 87.6% YoY, showing strong momentum
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.42x)
- Stock looks reasonably valued - P/E of 20.6 is below its historical median
- Company has a consistent dividend-paying track record
- Company comfortably covers its interest (10.7x coverage)
- Company generates healthy free cash flow
CONS
- Company has delivered a poor profit growth of 5.5% over past five years
- Company has delivered a poor sales growth of 7.0% over past five years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1901.00 | 37.71 | 456113.58 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8587.00 | 77.93 | 227957.87 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 4994.90 | 87.11 | 189989.94 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1437.65 | 34.46 | 116141.01 | 0.90 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1108.80 | 24.51 | 110603.22 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2203.10 | 18.22 | 100733.42 | 0.82 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | DRREDDY | 1181.35 | 30.60 | 98604.43 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 8. | MANKIND | 2385.00 | 48.22 | 98499.54 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 9. | LAURUSLABS | 1823.00 | 90.09 | 98498.92 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1606.40 | 24.90 | 92428.71 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 412.10 | 135.59 | 67159.70 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | HESTERBIO | 2405.50 | 15.03 | 2046.33 | 0.46 | 96.73 | 459.27 | 77.24 | -8.16 | 16.21 | 32.12 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 80 | 66 | 66 | 73 | 73 | 74 | 63 | 77 | 63 | 65 | 70 | 94 | 73 | |
| 69 | 54 | 54 | 60 | 60 | 59 | 54 | 63 | 51 | 53 | 54 | 62 | 55 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 4 | 1 |
| Depreciation | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 5 |
| 9 | 9 | 9 | 10 | 11 | 12 | 6 | 11 | 10 | 10 | 15 | 35 | 20 | |
| Tax % | 25.89% | 25.98% | 24.85% | 27.27% | 25.38% | 25.24% | 31.59% | 16.11% | 23.81% | 27.02% | 27.12% | 24.35% | 25.52% |
| Net Profit | 6 | 7 | 6 | 7 | 8 | 9 | 4 | 10 | 8 | 7 | 11 | 26 | 15 |
| 8 | 8 | 8 | 9 | 10 | 11 | 5 | 11 | 9 | 8 | 13 | 31 | 2 | |
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 80
- 69
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 3
- 9
- Tax %
- 25.89%
- Net Profit
- 6
- 8
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 66
- 54
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 3
- 9
- Tax %
- 25.98%
- Net Profit
- 7
- 8
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 66
- 54
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 3
- 9
- Tax %
- 24.85%
- Net Profit
- 6
- 8
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 73
- 60
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 10
- Tax %
- 27.27%
- Net Profit
- 7
- 9
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 73
- 60
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 11
- Tax %
- 25.38%
- Net Profit
- 8
- 10
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 74
- 59
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 12
- Tax %
- 25.24%
- Net Profit
- 9
- 11
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 63
- 54
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 2
- 6
- Tax %
- 31.59%
- Net Profit
- 4
- 5
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 77
- 63
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 11
- Tax %
- 16.11%
- Net Profit
- 10
- 11
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 63
- 51
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 10
- Tax %
- 23.81%
- Net Profit
- 8
- 9
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 65
- 53
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 10
- Tax %
- 27.02%
- Net Profit
- 7
- 8
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 70
- 54
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 15
- Tax %
- 27.12%
- Net Profit
- 11
- 13
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 94
- 62
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 4
- Depreciation
- 4
- 35
- Tax %
- 24.35%
- Net Profit
- 26
- 31
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 73
- 55
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 5
- 20
- Tax %
- 25.52%
- Net Profit
- 15
- 2
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 9
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 123 | 135 | 171 | 169 | 208 | 219 | 254 | 285 | 286 | 292 | 301 | |
| 82 | 85 | 103 | 117 | 136 | 159 | 199 | 238 | 236 | 224 | 223 | |
| Operating Profit | 42 | 51 | 71 | 56 | 74 | 65 | 60 | 52 | 56 | 80 | — |
| OPM % | 34 | 38 | 41 | 33 | 35 | 30 | 24 | 18 | 19 | 27 | — |
| Other Income | 1 | 2 | 3 | 3 | 2 | 5 | 6 | 5 | 5 | 12 | 8 |
| Interest | 3 | 2 | 4 | 5 | 4 | 2 | 6 | 5 | 5 | 7 | 8 |
| Depreciation | 6 | 5 | 8 | 9 | 10 | 10 | 10 | 10 | 9 | 10 | 13 |
| 33 | 44 | 60 | 41 | 55 | 53 | 44 | 37 | 42 | 70 | 79 | |
| Tax % | 25 | 30 | 27 | 24 | 27 | 26 | 26 | 26 | 24 | 25 | 25 |
| Net Profit | 25 | 31 | 44 | 31 | 40 | 40 | 32 | 27 | 32 | 52 | 59 |
| EPS | 29 | 36 | 52 | 37 | 47 | 46 | 38 | 32 | 37 | 61 | — |
| Dividend Payout % | 18 | 28 | 21 | 18 | 21 | 22 | 21 | 19 | 19 | 18 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 29 | 36 | 52 | 37 | 47 | 46 | 38 | 32 | 37 | 61 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 29 | 36 | 52 | 37 | 47 | 46 | 38 | 32 | 37 | 61 | — |
Mar 2017
- 123
- 82
- Operating Profit
- 42
- OPM %
- 34
- Other Income
- 1
- Interest
- 3
- Depreciation
- 6
- 33
- Tax %
- 25
- Net Profit
- 25
- EPS
- 29
- Dividend Payout %
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 29
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 29
Mar 2018
- 135
- 85
- Operating Profit
- 51
- OPM %
- 38
- Other Income
- 2
- Interest
- 2
- Depreciation
- 5
- 44
- Tax %
- 30
- Net Profit
- 31
- EPS
- 36
- Dividend Payout %
- 28
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 36
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 36
Mar 2019
- 171
- 103
- Operating Profit
- 71
- OPM %
- 41
- Other Income
- 3
- Interest
- 4
- Depreciation
- 8
- 60
- Tax %
- 27
- Net Profit
- 44
- EPS
- 52
- Dividend Payout %
- 21
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 52
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 52
Mar 2020
- 169
- 117
- Operating Profit
- 56
- OPM %
- 33
- Other Income
- 3
- Interest
- 5
- Depreciation
- 9
- 41
- Tax %
- 24
- Net Profit
- 31
- EPS
- 37
- Dividend Payout %
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 37
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 37
Mar 2021
- 208
- 136
- Operating Profit
- 74
- OPM %
- 35
- Other Income
- 2
- Interest
- 4
- Depreciation
- 10
- 55
- Tax %
- 27
- Net Profit
- 40
- EPS
- 47
- Dividend Payout %
- 21
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 47
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 47
Mar 2022
- 219
- 159
- Operating Profit
- 65
- OPM %
- 30
- Other Income
- 5
- Interest
- 2
- Depreciation
- 10
- 53
- Tax %
- 26
- Net Profit
- 40
- EPS
- 46
- Dividend Payout %
- 22
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 46
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 46
Mar 2023
- 254
- 199
- Operating Profit
- 60
- OPM %
- 24
- Other Income
- 6
- Interest
- 6
- Depreciation
- 10
- 44
- Tax %
- 26
- Net Profit
- 32
- EPS
- 38
- Dividend Payout %
- 21
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 38
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 38
Mar 2024
- 285
- 238
- Operating Profit
- 52
- OPM %
- 18
- Other Income
- 5
- Interest
- 5
- Depreciation
- 10
- 37
- Tax %
- 26
- Net Profit
- 27
- EPS
- 32
- Dividend Payout %
- 19
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 32
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 32
Mar 2025
- 286
- 236
- Operating Profit
- 56
- OPM %
- 19
- Other Income
- 5
- Interest
- 5
- Depreciation
- 9
- 42
- Tax %
- 24
- Net Profit
- 32
- EPS
- 37
- Dividend Payout %
- 19
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 37
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 37
Mar 2026
- 292
- 224
- Operating Profit
- 80
- OPM %
- 27
- Other Income
- 12
- Interest
- 7
- Depreciation
- 10
- 70
- Tax %
- 25
- Net Profit
- 52
- EPS
- 61
- Dividend Payout %
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 61
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 61
TTM
- 301
- 223
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 8
- Depreciation
- 13
- 79
- Tax %
- 25
- Net Profit
- 59
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 11%
- 5 Years:
- 7%
- 3 Years:
- 5%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 10%
- 5 Years:
- 5%
- 3 Years:
- 17%
STOCK PRICE CAGR
- 10 Years:
- 12%
- 5 Years:
- 0%
- 3 Years:
- 12%
- 1 Year:
- 16%
RETURN ON EQUITY
- 10 Years:
- 17%
- 5 Years:
- 12%
- 3 Years:
- 11%
- Last Year:
- 14%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| 114 | 138 | 171 | 195 | 229 | 260 | 284 | 304 | 331 | 377 | |
| 18 | 28 | 27 | 40 | 13 | 49 | 81 | 30 | 29 | 24 | |
| Trade Payables | 7 | 8 | 8 | 14 | 14 | 11 | 29 | 30 | 33 | 21 |
| 31 | 29 | 26 | 20 | 17 | 96 | 144 | 177 | 146 | 127 | |
| Total Liabilities | 178 | 210 | 240 | 277 | 282 | 424 | 546 | 550 | 546 | 557 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 61 | 67 | 101 | 97 | 87 | 84 | 108 | 103 | 105 | 288 | |
| Capital Work in Progress | 21 | 30 | 0 | 1 | 3 | 80 | 146 | 168 | 177 | 0 |
| 9 | 14 | 28 | 41 | 44 | 65 | 65 | 65 | 65 | 64 | |
| 33 | 39 | 48 | 60 | 57 | 71 | 79 | 69 | 59 | 60 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 86 | 81 | 92 | |
| Cash & Bank | 11 | 12 | 2 | 5 | 1 | 2 | 6 | 5 | 2 | 5 |
| 43 | 48 | 60 | 73 | 90 | 123 | 142 | 54 | 58 | 48 | |
| Total Assets | 178 | 210 | 240 | 277 | 282 | 424 | 546 | 550 | 546 | 557 |
| Total Debt | 39 | 43 | 38 | 48 | 16 | 122 | 164 | 134 | 104 | 74 |
| Net Working Capital | 41 | 47 | 60 | 65 | 105 | 92 | 80 | 107 | 89 | 98 |
| Contingent Liabilities | 1 | 1 | 28 | 106 | 103 | 106 | 115 | 117 | 120 | 133 |
| Book Value per Share | 143.52 | 171.72 | 210.93 | 238.72 | 279.28 | 315.54 | 343.70 | 367.59 | 398.60 | 452.78 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 39 | 43 | 38 | 48 | 16 | 122 | 164 | 134 | 104 | 74 |
| Net Working Capital | 41 | 47 | 60 | 65 | 105 | 92 | 80 | 107 | 89 | 98 |
| Contingent Liabilities | 1 | 1 | 28 | 106 | 103 | 106 | 115 | 117 | 120 | 133 |
| Book Value per Share | 143.52 | 171.72 | 210.93 | 238.72 | 279.28 | 315.54 | 343.70 | 367.59 | 398.60 | 452.78 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2017
- Equity Capital
- 9
- 114
- 18
- Trade Payables
- 7
- 31
- Total Liabilities
- 178
- 61
- Capital Work in Progress
- 21
- 9
- 33
- 0
- Cash & Bank
- 11
- 43
- Total Assets
- 178
- Total Debt
- 39
- Net Working Capital
- 41
- Contingent Liabilities
- 1
- Book Value per Share
- 143.52
- Face Value
- 10.00
- Total Debt
- 39
- Net Working Capital
- 41
- Contingent Liabilities
- 1
- Book Value per Share
- 143.52
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 9
- 138
- 28
- Trade Payables
- 8
- 29
- Total Liabilities
- 210
- 67
- Capital Work in Progress
- 30
- 14
- 39
- 0
- Cash & Bank
- 12
- 48
- Total Assets
- 210
- Total Debt
- 43
- Net Working Capital
- 47
- Contingent Liabilities
- 1
- Book Value per Share
- 171.72
- Face Value
- 10.00
- Total Debt
- 43
- Net Working Capital
- 47
- Contingent Liabilities
- 1
- Book Value per Share
- 171.72
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 9
- 171
- 27
- Trade Payables
- 8
- 26
- Total Liabilities
- 240
- 101
- Capital Work in Progress
- 0
- 28
- 48
- 0
- Cash & Bank
- 2
- 60
- Total Assets
- 240
- Total Debt
- 38
- Net Working Capital
- 60
- Contingent Liabilities
- 28
- Book Value per Share
- 210.93
- Face Value
- 10.00
- Total Debt
- 38
- Net Working Capital
- 60
- Contingent Liabilities
- 28
- Book Value per Share
- 210.93
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 9
- 195
- 40
- Trade Payables
- 14
- 20
- Total Liabilities
- 277
- 97
- Capital Work in Progress
- 1
- 41
- 60
- 0
- Cash & Bank
- 5
- 73
- Total Assets
- 277
- Total Debt
- 48
- Net Working Capital
- 65
- Contingent Liabilities
- 106
- Book Value per Share
- 238.72
- Face Value
- 10.00
- Total Debt
- 48
- Net Working Capital
- 65
- Contingent Liabilities
- 106
- Book Value per Share
- 238.72
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 9
- 229
- 13
- Trade Payables
- 14
- 17
- Total Liabilities
- 282
- 87
- Capital Work in Progress
- 3
- 44
- 57
- 0
- Cash & Bank
- 1
- 90
- Total Assets
- 282
- Total Debt
- 16
- Net Working Capital
- 105
- Contingent Liabilities
- 103
- Book Value per Share
- 279.28
- Face Value
- 10.00
- Total Debt
- 16
- Net Working Capital
- 105
- Contingent Liabilities
- 103
- Book Value per Share
- 279.28
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 9
- 260
- 49
- Trade Payables
- 11
- 96
- Total Liabilities
- 424
- 84
- Capital Work in Progress
- 80
- 65
- 71
- 0
- Cash & Bank
- 2
- 123
- Total Assets
- 424
- Total Debt
- 122
- Net Working Capital
- 92
- Contingent Liabilities
- 106
- Book Value per Share
- 315.54
- Face Value
- 10.00
- Total Debt
- 122
- Net Working Capital
- 92
- Contingent Liabilities
- 106
- Book Value per Share
- 315.54
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 9
- 284
- 81
- Trade Payables
- 29
- 144
- Total Liabilities
- 546
- 108
- Capital Work in Progress
- 146
- 65
- 79
- 0
- Cash & Bank
- 6
- 142
- Total Assets
- 546
- Total Debt
- 164
- Net Working Capital
- 80
- Contingent Liabilities
- 115
- Book Value per Share
- 343.70
- Face Value
- 10.00
- Total Debt
- 164
- Net Working Capital
- 80
- Contingent Liabilities
- 115
- Book Value per Share
- 343.70
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 9
- 304
- 30
- Trade Payables
- 30
- 177
- Total Liabilities
- 550
- 103
- Capital Work in Progress
- 168
- 65
- 69
- 86
- Cash & Bank
- 5
- 54
- Total Assets
- 550
- Total Debt
- 134
- Net Working Capital
- 107
- Contingent Liabilities
- 117
- Book Value per Share
- 367.59
- Face Value
- 10.00
- Total Debt
- 134
- Net Working Capital
- 107
- Contingent Liabilities
- 117
- Book Value per Share
- 367.59
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 9
- 331
- 29
- Trade Payables
- 33
- 146
- Total Liabilities
- 546
- 105
- Capital Work in Progress
- 177
- 65
- 59
- 81
- Cash & Bank
- 2
- 58
- Total Assets
- 546
- Total Debt
- 104
- Net Working Capital
- 89
- Contingent Liabilities
- 120
- Book Value per Share
- 398.60
- Face Value
- 10.00
- Total Debt
- 104
- Net Working Capital
- 89
- Contingent Liabilities
- 120
- Book Value per Share
- 398.60
- Face Value
- 10.00
Mar 2026
- Equity Capital
- 9
- 377
- 24
- Trade Payables
- 21
- 127
- Total Liabilities
- 557
- 288
- Capital Work in Progress
- 0
- 64
- 60
- 92
- Cash & Bank
- 5
- 48
- Total Assets
- 557
- Total Debt
- 74
- Net Working Capital
- 98
- Contingent Liabilities
- 133
- Book Value per Share
- 452.78
- Face Value
- 10.00
- Total Debt
- 74
- Net Working Capital
- 98
- Contingent Liabilities
- 133
- Book Value per Share
- 452.78
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 | 32 | 36 | 26 | 41 | 16 | 33 | 43 | 64 | 51 | |
| Cash from Investing | -15 | -26 | -25 | -21 | -4 | -111 | -72 | -21 | -19 | -2 |
| Cash from Financing | -6 | -6 | -20 | -1 | -41 | 95 | 41 | -24 | -46 | -48 |
| 6 | -0 | -9 | 3 | -4 | 0 | 3 | -2 | -1 | 0 | |
| Free Cash Flow | 12 | 12 | 25 | 21 | 41 | -68 | -60 | 16 | 47 | 38 |
| OCF / Net Profit | 1.10 | 1.06 | 0.83 | 0.83 | 1.03 | 0.40 | 1.03 | 1.58 | 2.01 | 0.98 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 111 | 31 | -41 | -50 | -24 | -27 |
| OCF / Net Profit | 1.10 | 1.06 | 0.83 | 0.83 | 1.03 | 0.40 | 1.03 | 1.58 | 2.01 | 0.98 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 111 | 31 | -41 | -50 | -24 | -27 |
Mar 2017
- 28
- Cash from Investing
- -15
- Cash from Financing
- -6
- 6
- Free Cash Flow
- 12
- OCF / Net Profit
- 1.10
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.10
- Cumulative 5-Year FCF
- 0
Mar 2018
- 32
- Cash from Investing
- -26
- Cash from Financing
- -6
- -0
- Free Cash Flow
- 12
- OCF / Net Profit
- 1.06
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.06
- Cumulative 5-Year FCF
- 0
Mar 2019
- 36
- Cash from Investing
- -25
- Cash from Financing
- -20
- -9
- Free Cash Flow
- 25
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 0
Mar 2020
- 26
- Cash from Investing
- -21
- Cash from Financing
- -1
- 3
- Free Cash Flow
- 21
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 0
Mar 2021
- 41
- Cash from Investing
- -4
- Cash from Financing
- -41
- -4
- Free Cash Flow
- 41
- OCF / Net Profit
- 1.03
- Cumulative 5-Year FCF
- 111
- OCF / Net Profit
- 1.03
- Cumulative 5-Year FCF
- 111
Mar 2022
- 16
- Cash from Investing
- -111
- Cash from Financing
- 95
- 0
- Free Cash Flow
- -68
- OCF / Net Profit
- 0.40
- Cumulative 5-Year FCF
- 31
- OCF / Net Profit
- 0.40
- Cumulative 5-Year FCF
- 31
Mar 2023
- 33
- Cash from Investing
- -72
- Cash from Financing
- 41
- 3
- Free Cash Flow
- -60
- OCF / Net Profit
- 1.03
- Cumulative 5-Year FCF
- -41
- OCF / Net Profit
- 1.03
- Cumulative 5-Year FCF
- -41
Mar 2024
- 43
- Cash from Investing
- -21
- Cash from Financing
- -24
- -2
- Free Cash Flow
- 16
- OCF / Net Profit
- 1.58
- Cumulative 5-Year FCF
- -50
- OCF / Net Profit
- 1.58
- Cumulative 5-Year FCF
- -50
Mar 2025
- 64
- Cash from Investing
- -19
- Cash from Financing
- -46
- -1
- Free Cash Flow
- 47
- OCF / Net Profit
- 2.01
- Cumulative 5-Year FCF
- -24
- OCF / Net Profit
- 2.01
- Cumulative 5-Year FCF
- -24
Mar 2026
- 51
- Cash from Investing
- -2
- Cash from Financing
- -48
- 0
- Free Cash Flow
- 38
- OCF / Net Profit
- 0.98
- Cumulative 5-Year FCF
- -27
- OCF / Net Profit
- 0.98
- Cumulative 5-Year FCF
- -27
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 29.32 | 35.92 | 51.55 | 36.70 | 46.90 | 46.45 | 38.02 | 31.93 | 37.43 | 61.24 |
| Book Value (₹) | 143.52 | 171.72 | 210.93 | 238.72 | 279.28 | 315.54 | 343.70 | 367.59 | 398.60 | 452.78 |
| Dividend per Share (₹) | 5.30 | 10.00 | 11.00 | 6.60 | 10.00 | 10.00 | 8.00 | 6.00 | 7.00 | 11.00 |
| Cash EPS (₹) | 35.79 | 42.33 | 60.44 | 47.74 | 58.23 | 57.62 | 49.52 | 43.42 | 47.52 | 73.29 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 33.29% | 38.06% | 41.39% | 32.85% | 35.32% | 29.48% | 23.53% | 16.42% | 17.77% | 23.18% |
| Net Margin % | 19.86% | 22.59% | 25.62% | 18.43% | 19.14% | 17.86% | 12.64% | 9.52% | 11.11% | 17.82% |
| ROE % | 22.43% | 22.79% | 26.94% | 16.33% | 18.11% | 15.62% | 11.53% | 8.98% | 9.77% | 14.39% |
| ROCE % | 24.16% | 26.28% | 31.15% | 19.74% | 23.28% | 17.31% | 11.91% | 9.26% | 10.59% | 17.02% |
| 14.79% | 15.71% | 19.46% | 12.07% | 14.27% | 11.19% | 6.67% | 4.96% | 5.81% | 9.44% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 77 | 79 | 69 | 83 | 79 | 85 | 99 | 108 | 106 | 108 |
| Inventory Days | 97 | 97 | 93 | 117 | 103 | 105 | 107 | 94 | 81 | 74 |
| Payable Days | 81 | 120 | 99 | 135 | 94 | 72 | 91 | 107 | 121 | 118 |
| 93 | 56 | 63 | 66 | 87 | 118 | 115 | 95 | 66 | 64 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.32x | 0.29x | 0.21x | 0.24x | 0.07x | 0.45x | 0.56x | 0.43x | 0.31x | 0.19x |
| Interest Coverage (x) | 11.31x | 19.88x | 17.87x | 9.19x | 14.88x | 22.58x | 7.76x | 8.21x | 8.78x | 10.72x |
| 2.20x | 2.10x | 2.53x | 2.12x | 4.03x | 2.22x | 1.58x | 2.09x | 1.92x | 2.06x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 22.19% | 9.33% | 27.01% | -1.03% | 23.05% | 5.22% | 15.80% | 12.27% | 0.46% | 1.98% |
| Operating Profit Growth % | 22.00% | 23.13% | 37.66% | -21.47% | 32.33% | -11.43% | -7.69% | -14.29% | 7.96% | 43.80% |
| Net Profit Growth % | 29.74% | 22.53% | 43.50% | -28.80% | 27.79% | -0.96% | -18.16% | -16.03% | 17.24% | 63.62% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -16.03% | 17.24% | 63.62% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 43.52x | 33.50x | 20.62x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 3.78x | 3.15x | 2.79x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.43% | 0.56% | 0.87% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 25.39x | 20.98x | 14.28x |
Mar 2017
- EPS (₹)
- 29.32
- Book Value (₹)
- 143.52
- Dividend per Share (₹)
- 5.30
- Cash EPS (₹)
- 35.79
- Operating Margin %
- 33.29%
- Net Margin %
- 19.86%
- ROE %
- 22.43%
- ROCE %
- 24.16%
- 14.79%
- Debtor Days
- 77
- Inventory Days
- 97
- Payable Days
- 81
- 93
- Debt to Equity (x)
- 0.32x
- Interest Coverage (x)
- 11.31x
- 2.20x
- Revenue Growth %
- 22.19%
- Operating Profit Growth %
- 22.00%
- Net Profit Growth %
- 29.74%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 35.92
- Book Value (₹)
- 171.72
- Dividend per Share (₹)
- 10.00
- Cash EPS (₹)
- 42.33
- Operating Margin %
- 38.06%
- Net Margin %
- 22.59%
- ROE %
- 22.79%
- ROCE %
- 26.28%
- 15.71%
- Debtor Days
- 79
- Inventory Days
- 97
- Payable Days
- 120
- 56
- Debt to Equity (x)
- 0.29x
- Interest Coverage (x)
- 19.88x
- 2.10x
- Revenue Growth %
- 9.33%
- Operating Profit Growth %
- 23.13%
- Net Profit Growth %
- 22.53%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 51.55
- Book Value (₹)
- 210.93
- Dividend per Share (₹)
- 11.00
- Cash EPS (₹)
- 60.44
- Operating Margin %
- 41.39%
- Net Margin %
- 25.62%
- ROE %
- 26.94%
- ROCE %
- 31.15%
- 19.46%
- Debtor Days
- 69
- Inventory Days
- 93
- Payable Days
- 99
- 63
- Debt to Equity (x)
- 0.21x
- Interest Coverage (x)
- 17.87x
- 2.53x
- Revenue Growth %
- 27.01%
- Operating Profit Growth %
- 37.66%
- Net Profit Growth %
- 43.50%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 36.70
- Book Value (₹)
- 238.72
- Dividend per Share (₹)
- 6.60
- Cash EPS (₹)
- 47.74
- Operating Margin %
- 32.85%
- Net Margin %
- 18.43%
- ROE %
- 16.33%
- ROCE %
- 19.74%
- 12.07%
- Debtor Days
- 83
- Inventory Days
- 117
- Payable Days
- 135
- 66
- Debt to Equity (x)
- 0.24x
- Interest Coverage (x)
- 9.19x
- 2.12x
- Revenue Growth %
- -1.03%
- Operating Profit Growth %
- -21.47%
- Net Profit Growth %
- -28.80%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 46.90
- Book Value (₹)
- 279.28
- Dividend per Share (₹)
- 10.00
- Cash EPS (₹)
- 58.23
- Operating Margin %
- 35.32%
- Net Margin %
- 19.14%
- ROE %
- 18.11%
- ROCE %
- 23.28%
- 14.27%
- Debtor Days
- 79
- Inventory Days
- 103
- Payable Days
- 94
- 87
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 14.88x
- 4.03x
- Revenue Growth %
- 23.05%
- Operating Profit Growth %
- 32.33%
- Net Profit Growth %
- 27.79%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 46.45
- Book Value (₹)
- 315.54
- Dividend per Share (₹)
- 10.00
- Cash EPS (₹)
- 57.62
- Operating Margin %
- 29.48%
- Net Margin %
- 17.86%
- ROE %
- 15.62%
- ROCE %
- 17.31%
- 11.19%
- Debtor Days
- 85
- Inventory Days
- 105
- Payable Days
- 72
- 118
- Debt to Equity (x)
- 0.45x
- Interest Coverage (x)
- 22.58x
- 2.22x
- Revenue Growth %
- 5.22%
- Operating Profit Growth %
- -11.43%
- Net Profit Growth %
- -0.96%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 38.02
- Book Value (₹)
- 343.70
- Dividend per Share (₹)
- 8.00
- Cash EPS (₹)
- 49.52
- Operating Margin %
- 23.53%
- Net Margin %
- 12.64%
- ROE %
- 11.53%
- ROCE %
- 11.91%
- 6.67%
- Debtor Days
- 99
- Inventory Days
- 107
- Payable Days
- 91
- 115
- Debt to Equity (x)
- 0.56x
- Interest Coverage (x)
- 7.76x
- 1.58x
- Revenue Growth %
- 15.80%
- Operating Profit Growth %
- -7.69%
- Net Profit Growth %
- -18.16%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 31.93
- Book Value (₹)
- 367.59
- Dividend per Share (₹)
- 6.00
- Cash EPS (₹)
- 43.42
- Operating Margin %
- 16.42%
- Net Margin %
- 9.52%
- ROE %
- 8.98%
- ROCE %
- 9.26%
- 4.96%
- Debtor Days
- 108
- Inventory Days
- 94
- Payable Days
- 107
- 95
- Debt to Equity (x)
- 0.43x
- Interest Coverage (x)
- 8.21x
- 2.09x
- Revenue Growth %
- 12.27%
- Operating Profit Growth %
- -14.29%
- Net Profit Growth %
- -16.03%
- -16.03%
- P/E (x)
- 43.52x
- P/B (x)
- 3.78x
- Dividend Yield %
- 0.43%
- 25.39x
Mar 2025
- EPS (₹)
- 37.43
- Book Value (₹)
- 398.60
- Dividend per Share (₹)
- 7.00
- Cash EPS (₹)
- 47.52
- Operating Margin %
- 17.77%
- Net Margin %
- 11.11%
- ROE %
- 9.77%
- ROCE %
- 10.59%
- 5.81%
- Debtor Days
- 106
- Inventory Days
- 81
- Payable Days
- 121
- 66
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- 8.78x
- 1.92x
- Revenue Growth %
- 0.46%
- Operating Profit Growth %
- 7.96%
- Net Profit Growth %
- 17.24%
- 17.24%
- P/E (x)
- 33.50x
- P/B (x)
- 3.15x
- Dividend Yield %
- 0.56%
- 20.98x
Mar 2026
- EPS (₹)
- 61.24
- Book Value (₹)
- 452.78
- Dividend per Share (₹)
- 11.00
- Cash EPS (₹)
- 73.29
- Operating Margin %
- 23.18%
- Net Margin %
- 17.82%
- ROE %
- 14.39%
- ROCE %
- 17.02%
- 9.44%
- Debtor Days
- 108
- Inventory Days
- 74
- Payable Days
- 118
- 64
- Debt to Equity (x)
- 0.19x
- Interest Coverage (x)
- 10.72x
- 2.06x
- Revenue Growth %
- 1.98%
- Operating Profit Growth %
- 43.80%
- Net Profit Growth %
- 63.62%
- 63.62%
- P/E (x)
- 20.62x
- P/B (x)
- 2.79x
- Dividend Yield %
- 0.87%
- 14.28x
Documents
Announcements
- Shareholders meeting
2026-08-04 - Hester Biosciences Limited has informed the Exchange regarding Notice of Postal Ballot
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-01 - Hester Biosciences Limited has informed the Exchange about Transcript
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026
Jan 2026